Sign inJoin waitlistJoin the waitlist

AF

Andres Forero-Torres

Physician · UNIVERSITY OF AL HL SVC FN

Credentials: · ·

History

UNIVERSITY OF AL HL SVC FN
Present

Hematology and Medical Oncology
1986–1989
Internal Medicine
1983–1986
Javeriana U
1979–1983

Research

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma
Journal of Clinical Oncology · 2012 · 1,166 citations
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas
New England Journal of Medicine · 2010 · Last of 7 authors · 1,022 citations
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Breast Cancer Research and Treatment · 2018 · 622 citations

Rita Nanda
22 papers
Hope Rugo
18 papers
Kathy Albain
16 papers
Nancy Bartlett
16 papers
Ranjana Advani
16 papers
ML
Minetta Liu
15 papers
Claudine Isaacs
13 papers
Douglas Yee
13 papers
Laura Esserman
13 papers
Angela DeMichele
12 papers
Jo Chien
12 papers
Amy Clark
11 papers

Clinical trials

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
Principal investigator · Completed · Phase 2
BioCryst Pharmaceuticals
2007–2011
Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
Principal investigator · Completed · Phase 1
Applied Molecular Evolution
2006–2009
Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer
Principal investigator · Completed · Phase 2
University of Alabama at Birmingham
2005–2006
BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
Study chair · Terminated · Phase 2
University of Alabama at Birmingham
2002–2005